Announcement
20 May 2020
In June 2020, the German authorities extended the scope of its investment screening to include certain pharmaceutical goods including medicine, medical products and personal protective equipment. The scope was extended following the outbreak of COVID-19.
Source
Number of interventions
1
1 certainly harmful
0 likely harmful
0 liberalising
Implementation date
03 Jun 2020
Revocation date:
No revocation date
On 2 June 2020, the German authorities issued 'Fünfzehnten Verordnung zur Änderung der Außenwirtschaftsverordnung' amending the scope of foreign investments subj...
See all
This state act is not part of any Thread yet.